TGTX
Tg Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.92 / 10
Netural
Sentiment and fund flow data show a mixed picture: fund flow score of 7.76 indicates robust liquidity, with small and medium inflows positive but large and extra-large blocks negative. Analyst consensus is neutral with only one opinion from Goldman Sachs. Overall, the stock enjoys some institutional interest yet faces skepticism from larger funds and analysts.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-15
InstitutionGoldman Sachs
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of TGTX?
- TGTX holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.92/10 (Netural).
